858675-55-5

Upstream product

• 109-73-9 N-butylamine 
• 858675-40-8 1,4-di-O-benzyl-2,3-O-isopropylidene-6-O-methanesulfonyl-α-L-sorbofuranose 
• 302788-32-5 1,4-di-O-benzyl-2,3-O-isopropylidene-α-L-sorbofuranose 

Downstream Products

• 858675-47-5 3,6-di-O-benzyl-N-butyl-2,4-di-O-butyl-1,5-dideoxy-1,5-imino-D-glucitol 
• 858675-45-3 3,6-di-O-benzyl-N-butyl-4-O-butyl-1,5-dideoxy-1,5-imino-D-glucitol 
• 858675-43-1 3,6-di-O-benzyl-N-butyl-2-O-butyl-1,5-dideoxy-1,5-imino-D-glucitol 
• 858675-41-9 3,6-di-O-benzyl-N-butyl-1,5-dideoxy-1,5-imino-D-glucitol 

Relevant academic research and scientific papers

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: The search for new therapeutic agents against Gaucher disease

A series of iminosugars bearing two or three alkyl chains ('iminoglycolipids') were designed as ceramide mimics and analogues of N-butyl 1-deoxynojirimycin (N-Bu DNJ, Zavesca). This orally active iminosugar inhibits the biosynthesis of glucosyl